bicalutamide
SpainDrugs containing this active substance
-
It is used to slow the growth of prostate tumors and improve the quality of life in men with inoperable metastatic prostate cancer who have undergone orchiectomy or are taking a medication called an LHRH agonist.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used for the treatment of advanced prostate cancer (in combination with other treatments or surgery) and for the treatment of non-metastatic prostate cancer in cases with a high risk of progression.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Almus Farmaceutica S.A.U.
-
It is used for the treatment of prostate cancer. It works by reducing the amount of testosterone produced by the body and can be prescribed alone or in combination with other treatments, such as radiotherapy or after prostate removal.
Form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used for the treatment of prostate cancer, acting by blocking the effects of male sex hormones such as testosterone.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used for the treatment of advanced prostate cancer (in combination with other treatments or surgery) and also for non-metastatic prostate cancer in cases with a high risk of disease progression.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used to treat certain prostate diseases, acting alongside other treatments that reduce the levels of male sex hormones in the body.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Kern Pharma S.L.
-
It is used for the treatment of advanced prostate cancer. It is taken together with a medication called a luteinizing hormone-releasing hormone (LHRH) analogue, an additional hormonal treatment, or alongside surgical removal of the testicles.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,0 mg Manufacturer: Mabo Farma S.A.
-
It is used in adult men to treat non-metastatic prostate cancer when there is a high risk of the disease progressing. It can be used alone or in combination with other treatments such as radiotherapy or surgery.
Form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg Manufacturer: Laboratorios Normon S.A.
-
It is used for the treatment of advanced prostate cancer (in combination with other drugs or surgery) and for the treatment of non-metastatic prostate cancer in cases with a high risk of progression.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Laboratorios Normon S.A.
-
It is used for the treatment of advanced prostate cancer, either in combination with additional hormonal treatment (luteinizing hormone-releasing hormone analogue) or alongside surgical removal of the testes.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,00 mg Manufacturer: Towa Pharmaceutical S.A.
-
It is used to treat prostate cancer, either as a single treatment in locally advanced stages or in combination with other treatments in advanced stages.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used for the treatment of advanced prostate cancer, either in combination with additional hormonal treatment (LHRH hormone analogues) or alongside surgical removal of the testes.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,00 mg Manufacturer: Laboratorio Stada S.L.
-
It is used for the treatment of advanced prostate cancer (in combination with other treatments or after surgery) and also for the treatment of non-metastatic prostate cancer in adult men when other treatments are not indicated or acceptable.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,00 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat certain prostate diseases, acting alongside other treatments that reduce male sex hormone levels in the body.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,00 mg Manufacturer: Biowise Pharmaceuticals, S.L.
-
It is used in adult men to treat non-metastatic prostate cancer when there is a high risk of the disease progressing. It can be used alone or in combination with radiotherapy or surgery.
Form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg Manufacturer: Laboratoires Juvise Pharmaceuticals
-
It is used for the treatment of advanced prostate cancer (in combination with other hormonal treatments or surgery) and for the treatment of non-metastatic prostate cancer in cases with a high risk of disease progression.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Laboratoires Juvise Pharmaceuticals
-
It is used for the treatment of advanced prostate cancer, in combination with additional hormonal therapy or surgical removal of the testicles.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.
-
It is used to treat certain prostate diseases, acting alongside other treatments to interfere with the action of male sex hormones.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,00 mg Manufacturer: Biowise Pharmaceuticals, S.L.
-
It is used for the treatment of advanced prostate cancer. It works by blocking the effects of male sex hormones to slow the growth of cells in the prostate.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg Manufacturer: Laboratorios Salvat S.A.
-
It is used in adult men to treat non-metastatic prostate cancer when there is a high risk of the disease progressing. It may be used alone or in combination with other treatments such as radiotherapy or surgery.
Form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg Manufacturer: Gp Pharm S.A.
-
It is used for the treatment of advanced prostate cancer (in combination with other treatments or surgery) and for non-metastatic prostate cancer in cases with a high risk of disease progression.
Form: tablets, film-coated
Active substance Dosage bicalutamide 50,0 mg Manufacturer: Gp Pharm S.A.